Move Over Retatrutide, Protagonist Just Became Your Antagonist
You love to see competition!
A new name just joined the obesity‑drug race and this one is not messing around.
Keep reading with a 7-day free trial
Subscribe to On The Pen to keep reading this post and get 7 days of free access to the full post archives.